Model Number 3CX*FX25RWC |
Device Problem
Use of Device Problem (1670)
|
Patient Problem
No Information (3190)
|
Event Date 07/24/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, it was noticed that the patient's blood in the arterial outline of the oxygenator was black.Unknown if there was any blood loss.Product was not changed out.Unknown if the procedure was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 4, 2018.(b)(4).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.(b)(4).The returned sample was visually inspected.It was discovered that the purge line and sampling line had been cut off and the gas outlet port had been deformed.The sample, after having been rinsed and dried was tested for its gas transfer performance in accordance with the factory's shipping inspection protocol.No anomalies were found and the obtained values met factory specification.During the gas transfer testing, the color of the blood in the arterial line was compared with that in the venous line and found to be brighter red than that in the venous line.A definitive root cause could not be determined; therefore, this complaint is not confirmed.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|